Real, Meaningful and Full of Mana: How to Make This Holiday Truly Your Own

MISSION, Kan., Nov. 25, 2025 (GLOBE NEWSWIRE) — (Family Features) The holidays rarely look like the glossy greeting-card version you grew up with, and that's a good thing. From mismatched chairs around the table to spontaneous drop-ins and burnt cookies, the festive season can be a little messy, and all the more wonderful for it. […]

Real, Meaningful and Full of Mana: How to Make This Holiday Truly Your Own

Real, Meaningful and Full of Mana: How to Make This Holiday Truly Your Own GlobeNewswire November 25, 2025 MISSION, Kan., Nov. 25, 2025 (GLOBE NEWSWIRE) — (Family Features) The holidays rarely look like the glossy greeting-card version you grew up with, and that's a good thing. From mismatched chairs around the table to spontaneous drop-ins

Professor Chan Heum Park’s Team at Hallym University Chuncheon Sacred Heart Hospital Sends Their Self-Developed “BioCabinet” to Space Aboard Nuri Rocket

Chan Hum Park, M.D.,Ph.D., Professor of Otolaryngology at Hallym University Chuncheon Sacred Heart Hospital and Director of the Nano-Bio Regenerative Medical Institute at Hallym University, leads the research team whose space biology payload, BioCabinet, will launch aboard the Nuri rocket's fourth flight on November 27, as part of the mission carrying the Next-Generation Medium Satellite-3.

STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Lawsuit

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub's September 2025 initial public offering (the “IPO”). A class action lawsuit has already been filed. If

JHX DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

(NYSE:JHX), NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of James Hardie Industries plc (NYSE: JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the “Class Period”) of the important December 23, 2025 lead plaintiff deadline. SO

JHX DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

JHX DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX GlobeNewswire November 25, 2025 NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of

ASBESTOS CORPORATION LIMITED PROVIDES UPDATE ON RESTRUCTURING

Asbestos Corporation Limited (“ACL” or the “Company”) (TSXV: AB.H) announced today that it continues to advance its restructuring efforts under theCompanies' Creditors Arrangement Act(“CCAA”), following the issuance of an initial order on May 6, 2025 and of an Amended and Restated Initial Order (“ARIO”) by the Superior Court of Québec (Commercial Division) (the “Court”) on

CPTN DEADLINE ALERT: ROSEN, A RANKED AND LEADING FIRM, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CPTN

New York, New York–(Newsfile Corp. – November 25, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in StubHub Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – STUB

Pomerantz LLP announces that a class action lawsuit has been filed against StubHub Holdings, Inc. (“StubHub” or the “Company”)(NYSE: STUB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia

(NASDAQ:ASND), – Prescription Drug User Fee Act (PDUFA) goal date extended by three months to February 28, 2026 COPENHAGEN, Denmark, Nov. 25, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) notified the Company that information submitted on November 5, 2025, related to the post-marketing

Scroll to Top